William Baumgartner, Benedict, Dirk
Esperance Pharmaceuticals Inc. is a biopharmaceutical company that develops novel anticancer agents. Esperance uses patented technologies from the LSU AgCenter, Pennington Biomedical Research Center, and LSU A&M as a foundation for their revolutionary cancer treatments. According to the company's website, their latest drug, EP-100, completed Phase 2 clinical trials in patients with advanced ovarian cancer.
Started in Baton Rouge, Louisiana, the company moved to Houston, Texas in 2015 to work with the MD Anderson Cancer Center and continue drug development.
For more information on Esperance Pharmaceuticals visit: http://www.esperancepharma.com/
The LSU AgCenter and the LSU College of Agriculture